Rokos Capital Management (UK)’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-273,694
Closed -$45.5M 250
2025
Q4
$45.5M Buy
+273,694
New +$45.8M 0.18% 60
2025
Q3
Sell
-73,107
Closed -$6.61M 229
2025
Q2
$6.61M Buy
+73,107
New +$5.78M 0.03% 168
2025
Q1
Sell
-256,032
Closed -$33.9M 197
2024
Q4
$33.9M Buy
+256,032
New +$24M 0.34% 48
2024
Q2
Sell
-20,000
Closed -$1.48M 130
2024
Q1
$1.48M Buy
+20,000
New +$1.48M 0.01% 85

Other funds holding ALAB

Rokos Capital Management (UK)'s ALAB Position: Q1 2026 in Review

Rokos Capital Management (UK) sold out of Astera Labs (ALAB) in Q1 2026, closing a stake of 273,694 shares — an estimated $45.5M sold.

Rokos Capital Management (UK) first reported a position in ALAB in Q1 2024 and held it in 4 quarters. The position peaked at $45.5M in Q4 2025. 707 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Rokos Capital Management (UK) reported no remaining Astera Labs position as of Q1 2026 after selling out during the quarter.
  • Rokos Capital Management (UK) sold 273,694 Astera Labs shares in Q1 2026, an estimated $45.5M.
  • Rokos Capital Management (UK) first reported a position in Astera Labs in Q1 2024 and held it in 4 quarters.
  • Rokos Capital Management (UK)'s Astera Labs position peaked at $45.5M in Q4 2025.
  • 707 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Rokos Capital Management (UK)'s 13F filing for Q1 2026, filed 15 May 2026.